Invention Grant
- Patent Title: Marker for response to antidepressant therapy
- Patent Title (中): 抗抑郁药治疗的标志物
-
Application No.: US14890584Application Date: 2014-05-13
-
Publication No.: US09459266B2Publication Date: 2016-10-04
- Inventor: Sabine Bahn , Man Kuan Chan , Viktoria Stelzhammer
- Applicant: Cambridge Enterprise Limited
- Applicant Address: GB Cambridge, Cambridgeshire
- Assignee: Cambridge Enterprise Limited
- Current Assignee: Cambridge Enterprise Limited
- Current Assignee Address: GB Cambridge, Cambridgeshire
- Agency: McDermott Will & Emery LLP
- Priority: GB1308518.8 20130513
- International Application: PCT/GB2014/051457 WO 20140513
- International Announcement: WO2014/184534 WO 20141120
- Main IPC: G01N33/92
- IPC: G01N33/92 ; G01N33/68
Abstract:
The invention relates to the use of ApoA4 as biomarker for predicting whether a patient will respond to antidepressant treatment. The invention further relates to methods and kits for predicting whether a patient will respond to antidepressant treatment using said biomarker.
Public/Granted literature
- US20160116492A1 MARKER FOR RESPONSE TO ANTIDEPRESSANT THERAPY Public/Granted day:2016-04-28
Information query
IPC分类:
